Advertisement
Advertisement
SLDB
Solid Biosciences Inc. Common Stock
9.71
USDSponsored
-0.18
-1.77%
Aug 26, 15:43 UTC -4
Open
SLDB Earnings Reports
Positive Surprise Ratio
SLDB beat 19 of 35 last estimates.
54%
Next Report
Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$0.45
Implied change from Q2 26 (Revenue/ EPS)
--
/+18.42%
Implied change from Q3 25 (Revenue/ EPS)
--
/-6.25%
Solid Biosciences Inc. Common Stock earnings per share and revenue
On Aug 06, 2026, SLDB reported earnings of -0.38 USD per share (EPS) for Q2 26, beating the estimate of -0.47 USD, resulting in a 20.44% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.67% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 12 analysts forecast an EPS of -0.45 USD, with revenue projected to reach -- USD, implying an increase of 18.42% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Eton Pharmaceutcials, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
$0.11
Actual
$0.35
Surprise
+198.38%
Alvotech Ordinary Shares
Report Date
Aug 19, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.11
Surprise
-300.00%
Abeona Therapeutics Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.23
Actual
-$0.35
Surprise
-49.19%
Prenetics Global Limited Class A Ordinary Share
Report Date
Aug 18, 2026 For Q2 26
Estimate
-$0.71
Actual
-$0.53
Surprise
+26.30%
Alpha Cognition Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.39
Actual
-$0.40
Surprise
-0.05%
Caribou Biosciences, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.32
Actual
-$0.24
Surprise
+25.74%
TuHURA Biosciences, Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+5.34%
Outlook Therapeutics, Inc. Common Stock
Report Date
Aug 14, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+5.46%
MiNK Therapeutics, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.61
Actual
-$0.62
Surprise
-1.31%
Lantern Pharma Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.28
Surprise
+27.76%
FAQ
What were Solid Biosciences Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Solid Biosciences Inc. Common Stock reported EPS of -$0.38, beating estimates by 20.44%, and revenue of $0.00, 0% as expectations.
How did the market react to Solid Biosciences Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -3.67%, changed from $8.71 before the earnings release to $8.39 the day after.
When is Solid Biosciences Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 02, 2026.
What are the forecasts for Solid Biosciences Inc. Common Stock's next earnings report?
Based on 12
analysts, Solid Biosciences Inc. Common Stock is expected to report EPS of -$0.45 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement